Want to see HK:6872 full AI Analyst Report?

TenNor Therapeutics Suzhou Ltd. Class H (6872) Financial Statements

― Followers

TenNor Therapeutics Suzhou Ltd. Class H Financial Overview

TenNor Therapeutics Suzhou Ltd. Class H's market cap is currently HK$6.54B. The company's EPS TTM is $; its P/E ratio is -36.12; TenNor Therapeutics Suzhou Ltd. Class H is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23
Income Statement
Total Revenue	¥ 0.00	¥ 0.00	¥ 0.00
Gross Profit	¥ 0.00	¥ 0.00	¥ 0.00
Operating Income	¥ -118.67M	¥ -78.00M	¥ -122.48M
EBITDA	¥ -150.18M	¥ -141.35M	¥ -186.61M
Net Income	¥ -153.24M	¥ -145.93M	¥ -191.84M
Balance Sheet
Cash & Short-Term Investments	¥ 183.76M	¥ 97.82M	¥ 58.11M
Total Assets	¥ 227.04M	¥ 132.89M	¥ 96.05M
Total Debt	¥ 28.65M	¥ 53.02M	¥ 59.42M
Net Debt	¥ -155.11M	¥ -44.79M	¥ 1.31M
Total Liabilities	¥ 73.18M	¥ 1.03B	¥ 854.96M
Stockholders' Equity	¥ 153.86M	¥ -898.05M	¥ -758.91M
Cash Flow
Free Cash Flow	¥ -87.65M	¥ -48.80M	¥ -98.63M
Operating Cash Flow	¥ -87.19M	¥ -48.60M	¥ -98.12M
Investing Cash Flow	¥ 2.50M	¥ -185.00K	¥ 70.38M
Financing Cash Flow	¥ 170.63M	¥ 88.50M	¥ 4.73M

Currency in CNY

TenNor Therapeutics Suzhou Ltd. Class H Earnings and Revenue History

Income Statement >

TenNor Therapeutics Suzhou Ltd. Class H Debt to Assets

Balance Sheet >

TenNor Therapeutics Suzhou Ltd. Class H Cash Flow

Cash Flow >

TenNor Therapeutics Suzhou Ltd. Class H Forecast EPS vs Actual EPS

Earnings >